| Target Price | $153.00 |
| Price | $87.39 |
| Potential | 75.08% |
| Number of Estimates | 39 |
| 39 Analysts have issued a price target CoreWeave 2027 . The average CoreWeave target price is $153.00. This is 75.08% higher than the current stock price. The highest price target is $318.15 264.06% , the lowest is $39.39 54.93% . | |
| A rating was issued by 46 analysts: 32 Analysts recommend CoreWeave to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CoreWeave stock has an average upside potential 2027 of 75.08% . Most analysts recommend the CoreWeave stock at Purchase. |
43 Analysts have issued a sales forecast CoreWeave 2026 . The average CoreWeave sales estimate is
This results in the following potential growth metrics:
37 Analysts have issued an CoreWeave EBITDA forecast 2026. The average CoreWeave EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
41 CoreWeave Analysts have issued a net profit forecast 2026. The average CoreWeave net profit estimate is
This results in the following potential growth metrics and future Net Margins:
41 Analysts have issued a CoreWeave forecast for earnings per share. The average CoreWeave EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 02 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| William Blair |
➜
Outperform
|
Initiated | Sep 30 2026 |
| Freedom Capital Markets |
Buy
➜
Buy
|
Unchanged | Sep 30 2026 |
| JP Morgan |
Neutral
➜
Overweight
|
Upgrade | Sep 24 2026 |
| UBS |
➜
Buy
|
Initiated | Sep 23 2026 |
| Rothschild & Co |
➜
Sell
|
Initiated | Sep 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 02 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Oct 01 2026 |
|
Initiated
William Blair:
➜
Outperform
|
Sep 30 2026 |
|
Unchanged
Freedom Capital Markets:
Buy
➜
Buy
|
Sep 30 2026 |
|
Upgrade
JP Morgan:
Neutral
➜
Overweight
|
Sep 24 2026 |
|
Initiated
UBS:
➜
Buy
|
Sep 23 2026 |
|
Initiated
Rothschild & Co:
➜
Sell
|
Sep 21 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


